ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1428	National Cancer Institute	Html	null	Retinoblastoma Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of retinoblastoma in children.			CLICK HERE
1657	National Cancer Institute	Html	en	Childhood Central Nervous System Embryonal Tumors Treatment (PDQ®)–Health Professional Version	Expert-reviewed information summary about the treatment of childhood medulloblastoma, nonmedulloblastoma embryonal tumors, and pineal tumors.	adjuvant chemotherapy 0.284178 primitive neuroectodermal tumors 0.441731 Low-stage medulloblastoma 0.276631 standard risk medulloblastoma 0.295812 craniospinal radiation therapy 0.289613 prognostic factors 0.298331 chemotherapy 0.308667 high-risk disseminated medulloblastoma 0.295264 medulloblastoma extent 0.319739 metastatic medulloblastoma 0.292959 early childhood medulloblastoma 0.501191 brain tumors 0.331694 children 0.47617 von Bueren AO 0.264775 young children 0.341987 Cancer Group 0.327468 Radiat Oncol Biol 0.296868 WNT medulloblastoma cases 0.313174 medulloblastoma 0.767685 nonmedulloblastoma embryonal tumors 0.263341 medulloblastoma subgroups 0.365378 paediatric medulloblastoma 0.27996 von Hoff 0.292117 desmoplastic/nodular medulloblastoma 0.301127 desmoplastic medulloblastoma 0.355762	syndrome-associated childhood medulloblastoma 0.323686 medulloblastoma patients 0.341131 Clin Cancer Res 0.271749 radiation therapy 0.321079 Acta Neuropathol 0.331155 et al. 0.786797 Pediatr Blood Cancer 0.60557 pineal gland cyst 0.276571 medulloblastoma resection 0.293465 standard-risk medulloblastoma 0.318484 average-risk medulloblastoma 0.337894 Medulloblastoma variants 0.320092 Abstract 0.770373 Clin Oncol 0.950195 pediatric medulloblastoma 0.392703 Oncol Biol Phys 0.298432 embryonal tumors 0.349688 medulloblastoma resections 0.29489 nonmetastatic medulloblastoma 0.294586 embryonal brain tumors 0.299215 newly diagnosed medulloblastoma 0.289358 medulloblastoma subtypes 0.331966 complexity underlying medulloblastoma 0.308738 WNT medulloblastoma tumors 0.354112	CLICK HERE
1752	National Cancer Institute	Html	en	Common Moles, Dysplastic Nevi, and Risk of Melanoma	A fact sheet about moles and how some moles may be related to melanoma, the most serious type of skin cancer. Includes photos of differences between moles and cancer.	skin cancer 0.396204 new pencil eraser 0.340631 new mole 0.324515 people—have common moles 0.296925 areas 0.255107 Cancer Statistics Review 0.258106 skin surface 0.252994 American Cancer Society 0.291862 dysplastic nevi 0.760688 ABCDE features 0.255948 shape 0.300226 normal moles 0.26535 melanoma 0.905882 new moles 0.27436 distinct edge 0.298497 UV radiation 0.254044 mole look 0.348624 early melanoma 0.368768 color changes 0.261127 following changes 0.256625 moderately increased chance 0.26864 dysplastic nevus 0.99874 dark skin 0.328273 skin damage 0.265216	new colored area 0.350978 mole changes 0.343324 skin 0.706105 people—develop melanoma 0.334635 cancer cells 0.262185 sun 0.303017 atypical mole 0.288433 National Cancer Institute 0.258053 frequent skin exam 0.273598 common moles 0.677867 chance 0.337967 greater chance 0.265511 American adults—about 0.256684 surface texture 0.317122 Evolving. The mole 0.285916 people 0.632361 doctor 0.289469 normal skin tone 0.268972 family history 0.256672 early melanoma detection 0.355222 unusual mole 0.314622 common mole 0.732427 common mole look 0.339723 fair skin 0.271925	CLICK HERE
1789	National Cancer Institute	Html	es	Complicaciones gastrointestinales (PDQ®)–Versión para pacientes	Resumen de información revisada por expertos acerca del estreñimiento, impacción, obstrucción intestinal y diarrea como complicaciones del cáncer o su tratamiento. Se discute el manejo de estos problemas.	PDQ Complicaciones 0.530388 pelvis causa inflamación 0.572317 siguientes procedimientos 0.608568 hormona tiroidea 0.545669 siguientes aspectos 0.533891 Lactobacillus acidophilus 0.526037 rayos x 0.532507 media hora 0.541392 diarrea aguda 0.693188 largo plazo 0.569789 siguientes preguntas 0.540731 Busque privacidad 0.543195 productos lácteos 0.560479 medicamentos iv 0.544267 siguientes indicaciones 0.527177 tratamiento quizás 0.572007 vía iv 0.522455 cáncer.ampliar colonoscopia 0.551466 Instituto Nacional 0.536707 Coma porciones 0.524947 heces retenidas 0.545367 intestino.ampliar procedimiento 0.541183 suficiente ejercicio 0.545879 crónica.Obstrucción intestinal aguda 0.64888	pacientes quizás 0.581825 síntomas quizás 0.540102 metabolismo corporal concentración 0.581977 cantidades correctas 0.533739 régimen brat 0.52571 ¿El estreñimiento 0.640368 medicamentos opioides 0.717569 ejercicio lesión 0.545303 gráfico muestra afecciones 0.567465 National Cancer Institute 0.520678 La nutrición 0.589361 alto contenido 0.5222 siguientes signos 0.535436 Physician Data Query 0.576854 enzimas pancreáticas 0.556797 radiación aguda 0.557929 cuerpo).ampliar anatomía 0.552347 Radiografía abdominal 0.535361 suficiente cantidad 0.531328 enteritis aguda 0.993176 siguientes complicaciones 0.586671 obstrucción intestinal aguda 0.803119 cirugía.Algunos medicamentos 0.559484 siguientes pruebas 0.618199	CLICK HERE
1823	National Cancer Institute	Html	es	Tratamiento del sarcoma de tejido blando en adultos (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del sarcoma de tejido blando en adultos.	Scandinavian Sarcoma Group 0.539831 Lippincott Williams 0.562481 bEl tumor 0.509518 Compton CC 0.522215 Cancer Institute Surveillance 0.506324 Antonescu CR 0.5084 Sarcoma Group 0.551693 Sin embargo 0.587887 tumor center 0.509169 observación versus 0.507069 largo plazo 0.5106 7th ed 0.522519 DeVita VT Jr 0.615914 from sarcomas 0.514899 Tumores osteocondrales.Condrosarcomas 0.512024 Prognostic factors 0.507702 lymph nodes 0.507203 Rosenberg SA 0.558836 T1b Tumor 0.509623 tumor lipomatoso atípico 0.511636 soft tissue sarcoma 0.94016 Lawrence TS 0.559677 fibroso maligno 0.507755 Cancer Centers Sarcoma 0.522459 localised limb soft 0.508432	sarcoma patients 0.519354 metastasis from soft 0.508028 Tumores vasculares.Hemangioendotelioma 0.512057 O'Sullivan B 0.529169 tratamiento adyuvante versus 0.512692 versus quimioterapia 0.510953 Malawer MM 0.508085 Nielsen T 0.507472 Tumores adipocíticos.Liposarcoma 0.51216 Cancer Staging Manual 0.545483 Maki RG 0.50832 potencial metastásico 0.508732 recidivas locales 0.527298 New York 0.519322 9th ed 0.564335 high risk soft 0.507723 adult soft tissue 0.530167 Byrd DR 0.520996 T2b Tumor 0.50961 mutación genética ptc 0.506056 Helman LJ 0.508415 Sarcoma Group study 0.521636 Molecular biology 0.507762 AJCC Cancer Staging 0.547586	CLICK HERE
1854	National Cancer Institute	Html	es	Tratamiento del melanoma ocular uveal (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del melanoma ocular uveal.	Lippincott Williams 0.0202121 Compton CC 0.0326793 intraocular melanoma 0.187253 Singh AD 0.0183835 mortality findings 0.0177193 initial mortality findings 0.0168176 Collaborative Ocular Melanoma 0.845271 tumores coroideos 0.0533438 concerning uveal melanomas 0.0413676 transformation into melanoma 0.0471527 7th ed 0.0334776 melanoma intraocular uveal 0.0617166 transpupillary thermotherapy 0.0364759 choroidal melanoma 0.885011 Ophthalmol Clin 0.0328664 melanoma coroideo 0.351056 Radiat Oncol Biol 0.049169 DeVita VT Jr 0.0170972 coms report 0.12083 Iris melanomas 0.0424181 choroidal melanoma ii 0.0483613 small choroidal melanoma 0.146057 from intraocular melanoma 0.0447667 metastatic melanoma 0.0397711 Ocular Melanoma Study 0.837498	Shields JA 0.126368 Diffuse choroidal melanoma 0.048527 COMS randomized 0.0359843 melanomas coroideos 0.0974806 uveal melanomas 0.9898 Melanoma Study Group 0.158608 Malignant melanoma 0.12436 from uveal melanoma 0.0570651 Cancer Staging Manual 0.0611746 uveal melanoma management 0.0496842 COMS Medium Tumor 0.0243028 Arch Ophthalmol 0.4179 large choroidal melanoma 0.0789386 New York 0.0440447 cLos melanomas 0.0368816 Diener-West M 0.0182158 large uveal melanomas 0.0943176 Oncol Biol Phys 0.0503576 malignant uveal melanoma 0.051425 unrecognized choroidal melanoma 0.0480539 Byrd DR 0.0304967 Shields CL 0.154709 Int Ophthalmol Clin 0.0287474 AJCC Cancer Staging 0.0646958	CLICK HERE
1869	National Cancer Institute	Html	es	Tratamiento del sarcoma de tejido blando infantil (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos acerca del tratamiento del sarcoma de tejido blando infantil.	Pediatric Oncology 0.427738 Childhood soft tissue 0.412657 Sarcoma Group 0.408529 soft part sarcoma 0.421702 Pediatr Surg Int 0.410488 tumor >5 cm 0.40873 Neonatal soft tissue 0.41137 pediatric nonrhabdomyosarcoma soft 0.423413 soft-tissue sarcoma 0.42357 oncology group study 0.42018 sarcoma necessary after 0.409292 Children's Oncology Group 0.423153 sarcoma results 0.408962 undifferentiated sarcoma 0.409416 5th ed 0.408863 pediatric soft tissue 0.468096 Weiss's Soft Tissue 0.465072 soft tissue sarcoma 0.984779 low-grade fibromyxoid sarcoma 0.417727 Jude Children Research 0.411214 lower extremity sarcomas 0.408827 nonrhabdomyosarcoma soft 0.450499 sarcoma patients 0.409132 End Results 0.409463 Surg Pathol 0.410619	cuello sarcoma 0.408715 Ferrari A 0.410275 Pediatr Blood Cancer 0.449691 Cancer Staging Manual 0.440273 Weiss SW 0.438749 Genes Chromosomes Cancer 0.409368 Translocation-related sarcomas 0.408627 Surg Oncol 0.422483 Adult-type soft tissue 0.411539 Sarcomas embrionarios 0.408595 Pediatr Surg 0.44479 part sarcoma fuses 0.409332 Clin Oncol 0.434253 Children's Research Hospital 0.410798 Goldblum JR 0.438633 sarcomas with surgery 0.409572 soft tissue tumors 0.508399 Pediatric Oncology Group 0.420884 >5 cm 0.415115 retroperitoneo sarcoma 0.408795 round cell tumor 0.41657 Oncology Group 0.440064 localized soft-tissue sarcomas 0.40921 AJCC Cancer Staging 0.461396	CLICK HERE
2026	National Cancer Institute	Html	es	Prevención del cáncer colorrectal (PDQ®)–Versión para profesionales de salud	Sumario de información revisada por expertos sobre factores que influyen en el riesgo de presentar cáncer colorrectal y sobre las investigaciones dirigidas a la prevención de esta enfermedad.	colorectal adenoma chemoprevention 0.338068 colorectal neoplasia among 0.319011 long-term risk 0.313313 Adults With Colorectal 0.319346 Sin embargo 0.339382 Gastrointest Endosc 0.311269 largo plazo 0.32477 CPS II 0.314437 flexible sigmoidoscopy screening 0.31731 Preventive Services Task 0.332229 colorectal cancer 0.908646 population-based study 0.314294 Estados Unidos 0.331084 Natl Cancer Inst 0.334301 Women's Health Study 0.324602 after colonoscopy 0.309105 CCR multivariantes 0.345859 Aspirin Trial 0.311104 Women's Health Initiative 0.338408 colorectal adenomatous polyps 0.317676 Health Initiative 0.348288 colorrectal hereditario 0.317986 Women's Health 0.346194 cancer prevention 0.326424 Rothwell PM 0.314674	colorectal adenoma 0.357654 Health Study 0.364941 sporadic colorectal adenomas 0.324242 RR multivariante 0.309686 CCR clínico 0.37477 Health Study Research 0.310687 left-sided colorectal neoplasms 0.31858 primary prevention 0.311318 Hereditary Cancer Syndromes 0.314398 Epidemiol Biomarkers Prev 0.320559 arteriopatía coronaria 0.30952 riesgo promedio 0.330242 antecedentes familiares 0.330027 Cancer Prevention Study 0.318847 Intern Med 0.471733 cohort study using 0.309014 Clin Oncol 0.310431 Services Task Force 0.331368 systematic review 0.369209 Giovannucci E 0.31569 physical activity 0.319835 Protection from 0.309663 Women’s Health Initiative 0.324227 with colorectal cancer 0.348991	CLICK HERE
2066	National Cancer Institute	Html	es	Los cuidados al final de la vida de personas con cáncer	Hoja informativa que responde algunas de las preguntas que tienen muchos pacientes, sus familiares y quienes cuidan de ellos acerca del final de la vida.	desechos quizás 0.586339 pequeñas porciones 0.540804 alcance objetos 0.559532 suficientes glóbulos 0.562578 causa hinchazón 0.558057 dosis correctos 0.546349 médicos cuánto tiempo 0.63336 suficiente oxígeno 0.652738 cuánto tiempo 0.903324 suficiente tejido 0.550065 paciente experimenta síntomas 0.986626 paciente quizás 0.789052 considerable agitación 0.540843 quizás querrán 0.579319	menor flujo 0.542617 presente somnolencia 0.544492 reducida capacidad 0.540414 persona enferma causa 0.731054 malos días 0.539357 mejores cuidadores 0.583437 Mayor debilidad 0.544974 falsas esperanzas 0.572246 siguientes situaciones 0.566454 cuerpo boca 0.542456 familia esté lista 0.658292 paciente presente incontinencia 0.756496 persona quizás 0.668635	CLICK HERE
3455	National Cancer Institute	Html	es	Acupuntura (PDQ®)–Versión para profesionales de salud	Resumen de información revisada por expertos sobre la acupuntura como tratamiento para las personas con cáncer o trastornos relacionados con esta enfermedad.	Zhang G 0.32606 chinese herbs 0.319163 Niemtzow RC 0.320654 Ghaly RG 0.32227 cáncer gástrico grupo 0.319634 splenic natural killer 0.318671 consecutivos dolor 0.340228 acupuntura versus 0.39936 Pharmacol Biochem Behav 0.321201 Yang J 0.320136 cáncer grupo 0.365962 ECA Dolor 0.328485 Chinese Acupuncture 0.324024 traditional chinese 0.334765 Estados Unidos 0.464193 Oriental Medicine 0.333741 Zhongguo Zhong Xi 0.337599 its regulative function 0.324075 Med Hist 0.316569 Mod Med Asia 0.316861 Zhong Xi Yi 0.336593 Pain Symptom Manage 0.370153 Xi Yi Jie 0.336643 Altern Complement Med 0.372332 Complement Ther Med 0.320059	Hand Acupuncture Therapy 0.319232 killer cell cytotoxicity 0.32019 Acupuncture techniques 0.319086 Curr Probl Cancer 0.317979 acupuntura guanyuan 0.365152 Tradit Chin Med 0.903597 alternative medicine 0.411597 Churchill Livingstone 0.334944 Dundee JW 0.395667 New York 0.354273 Soc Med 0.364691 systematic review 0.333425 cáncer óseo 0.319179 Zhang RX 0.320688 Acupuncture stimulation enhances 0.344465 acupuntura mejora 0.364667 treated with 0.328504 Desconocida Sí 0.317149 chinese medicine 0.449414 Za Zhi 0.321785 Acupuncture prophylaxis 0.318487 Liu B 0.317806 stimulation enhances splenic 0.322832 Fitzpatrick KT 0.320501	CLICK HERE